top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Autore Vermehren Charlotte
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (224 p.)
Soggetto topico Manufacturing industries
Medicine and Nursing
Soggetto non controllato 2019 Beers criteria
5'nuclease assay
80 and over
abacavir
acute kidney injury
adverse drug reaction
adverse drug reactions
aged
allopurinol
antidepressants
antiepileptic drugs
antipsychotics
appropriateness
bleeding
children
chronic
clinical pharmacist
clozapine
CNV
copy number variation
cost-effectiveness
CYP1A2
CYP2D6
CYP2D7P
CYP2D8P
cytochrome P450
cytochromes
deprescribing
deprescriptions
determinants
digital decision-support
digital health
DOACs
drug hypersensitivity
drug information service
drug interaction checkers
drug metabolization
drug-drug interactions
drug-gene interactions
early biomarker
electronic medical record
electronic prescribing
emergency department
Ethiopia
exosomes
extracellular vesicles
flucloxacillin
general practice
genotyping
health outcomes
health services research
high resolution melting
HLA
hospital pharmacy service
HRM
loxapine
medication adherence
medication optimization
medication reconciliation
medication review
medication-based risk score
microvesicles
multimorbidity
nursing homes
olanzapine
older adults
older patients
outpatient
personalized medicine
persons with diabetes
pharmacogene expression
pharmacogenetics
pharmacogenomics
phenprocoumon
plasma neutrophil gelatinase-associated lipocalin
polypharmacy
population-based
potentially inappropriate medication use
prevalence
process evaluation
quality of life
shared medication record
SLCO1B1
soluble urokinase plasminogen activator receptor
thromboembolism
utility
youth
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Record Nr. UNINA-9910595072903321
Vermehren Charlotte  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug-Drug Interactions
Drug-Drug Interactions
Autore Kim Dong Hyun
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (242 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato (‒)-sophoranone
1A2
2B6
2C19
2C8
2C9
2D6
3A4
ADME
adverse drug reactions
biflavonoid
chronic kidney disease
competitive inhibition
computational prediction
CYP
CYP1A1
CYP1A2
CYP2C9
CYP2D6
CYP3A
CYP3A4
cytochrome P450
cytochromes P450
DDI
Dexamethasone
drug interaction
drug interactions
drug metabolism
drug transporter
drug-drug interaction
drug-drug interactions
expression
fexofenadine
gepants
high plasma protein binding
in silico
in vitro
in vivo
inhibitor
ixazomib
Ketoconazole
lasmiditan
Lexicomp
low permeability
Loxoprofen
mechanism-based inhibition
metabolic DDI
metabolism
migraine
monoclonal antibodies
non-competitive inhibition
O-desmethyltramadol
OATP1B1
OATP1B3
organic anion transporting polypeptide 1A2 (OATP1A2)
P-glycoprotein (P-gp)
P450
pharmacokinetics
physiologically-based pharmacokinetics
plasma concentration
polypharmacy
potent inhibition
QSAR
regulation
Rumex acetosa
selamariscina A
signal detection algorithms
spontaneous reporting systems
subset analysis
substrate
systemic exposure
tadalafil
ticagrelor
tissue-specific
tramadol
tyrosine kinase inhibitors
ubiquitination
uridine 5'-diphosphoglucuronosyl transferase
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557666403321
Kim Dong Hyun  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui